Abstract:Cell signaling mechanisms modulate gene expression in response to internal and external stimuli. Cellular adaptation requires a precise and coordinated regulation of the transcription and translation processes. The post-transcriptional control of mRNA metabolism is mediated by the so-called RNA-binding proteins (RBPs), which assemble with specific transcripts forming messenger ribonucleoprotein particles of highly dynamic composition. RBPs constitute a class of trans -acting regulatory proteins with affinity for certain consensus elements present in mRNA molecules. However, these regulators are subjected to post-translational modifications (PTMs) that constantly adjust their activity to maintain cell homeostasis. PTMs can dramatically change the subcellular localization, the binding affinity for RNA and protein partners, and the turnover rate of RBPs. Moreover, the ability of many RBPs to undergo phase transition and/or their recruitment to previously formed membrane-less organelles, such as stress granules, is also regulated by specific PTMs. Interestingly, the dysregulation of PTMs in RBPs has been associated with the pathophysiology of many different diseases. Abnormal PTM patterns can lead to the distortion of the physiological role of RBPs due to mislocalization, loss or gain of function, and/or accelerated or disrupted degradation. This Mini Review offers a broad overview of the post-translational regulation of selected RBPs and the involvement of their dysregulation in neurodegenerative disorders, cancer and other pathologies.

The effect of RNA binding proteins on neurodevelopment and neurological disease

RNA-binding proteins in neurological development and disease

RNA-Binding Proteins Hold Key Roles in Function, Dysfunction, and Disease

Roles of RNA-binding proteins in neurological disorders, COVID-19, and cancer

RNA-binding proteins in human genetic disease

Unraveling the Pathways to Neuronal Homeostasis and Disease: Mechanistic Insights into the Role of RNA-Binding Proteins and Associated Factors

87 Overexpression of mitochondrial Leucyl-tRNA synthetase restore the mitochondrial dysfunctions caused by the MELAS-associated tRNALeu(UUR) A3243G mutation

Regulation of DNA damage response by RNA/DNA-binding proteins: Implications for neurological disorders and aging

Recent Progress in the Research on RNA-Binding Proteins in Bone Development and Diseases

RNA-binding proteins in tumor progression

The role of CELF family in neurodevelopment and neurodevelopmental disorders

RNA Binding Proteins: Mechanistic Considerations and Perspectives in Controlling Cardiovascular Diseases

RNA-Binding Proteome Analysis and Functional Explorations

The Biological Mechanisms and Clinical Roles of RNA-Binding Proteins in Cardiovascular Diseases

RNA-binding proteins and post-transcriptional gene regulation

Role of RNA binding proteins of the Drosophila behavior and human splicing (DBHS) family in health and cancer

How Do RNA Binding Proteins Trigger Liquid-Liquid Phase Separation in Human Health and Diseases?

New insights into the function and therapeutic potential of RNA-binding protein TRBP in viral infection, chronic metabolic diseases, brain disorders and cancer

Post-translational Control of RNA-Binding Proteins and Disease-Related Dysregulation

Altered mRNA transport and local translation in iNeurons with RNA binding protein knockdown

Genome-wide landscape of RNA-binding protein target site dysregulation reveals a major impact on psychiatric disorder risk